Bevacizumab is the first antiangiogenic therapy to...

Maintenance with PARP inhibitor is the way forward...

Liquid biopsy in non small cell lung cancer is now...

Median survival in metastatic carcinoma breast is ...

Cancer treatment is complex and requires a team of...

Is it possible to avoid chemotherapy in Breast Can...

ERA OF PERSONALISED MEDICINE IN METASTATIC ADENOCA...

IMMUNOTHERAPY IN LUNG CANCER- THE FUTURE OF CANCER...